The NIBSC Scientific Advisory Committee (SAC) was re-established in 2014. Its aim is to provide independent expert advice, scrutiny and oversight across the increasingly broad range of scientific work at NIBSC and its science strategy, and provide assurance to the Medicines and Healthcare Products Regulatory Agency and to the Department of Health about the Institute’s activities.
The chair of the new SAC is one of the Medicines and Healthcare Products Regulatory Agency’s Agency Board members, Professor David Webb (Department of Cardiology, Edinburgh University).
SAC members provide expertise in the areas considered to be important for the NIBSC’s future scientific development.
Professor David J Webb (Committee Chair and MHRA Board Member)
Dr Jonathan Graves
The terms of reference for the committee are: